24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
On 27 November 2018, members of the Oxford PharmaGenesis Patient Engagement Team were delighted to attend the annual Pharmaceutical Marketing Society meeting in London to discuss with industry, healthcare and patient organization stakeholders what a more informed patient means for healthcare.
Oxford PharmaGenesis was proud to participate in and support the first European annual meeting of the Medical Affairs Professionals Society (MAPS), which took place on 21–23 October 2018, in Berlin, Germany.
Earlier this month, Oxford PharmaGenesis was delighted to attend the 9th World Orphan Drug Congress (WODC) in Barcelona, Spain.
Open Pharma reached the finals of the Community Partnership of the Year Award category at this year’s prestigious Scrip awards.
Members of the Oxford PharmaGenesis Patient Engagement team attended the 4th Annual Rare Disease Patient Network Meeting in Cardiff, UK, on Thursday 18 October, along with patients, carers and patient advocates.
HealthScience experts from the Oxford PharmaGenesis Patient Engagement team attended the 2018 Patient Summit Europe in London (16–17 October), which brought together pharma stakeholders, patients and patient advocates.
